RE: BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

J Natl Cancer Inst. 2016 Aug 31;108(12):djw172. doi: 10.1093/jnci/djw172. Print 2016 Dec.

Authors

Eloisa Arbustini¹, Adele Sgarella², Alberta Ferrari², Donatella Grasso², Chiara Cassani², Marco Lucioni², Giuseppe Di Giulio², Maurizia Grasso²

Affiliations

¹ Centre for Inherited Diseases (EA, MG), Breast Unit (AS, AF), Oncology (DG), Gynecology (CC), Pathology (ML), and Radiology (GDG), IRCCS Foundation Policlinico San Matteo, Pavia, Italy e.arbustini@smatteo.pv.it.
² Centre for Inherited Diseases (EA, MG), Breast Unit (AS, AF), Oncology (DG), Gynecology (CC), Pathology (ML), and Radiology (GDG), IRCCS Foundation Policlinico San Matteo, Pavia, Italy.

PMID: 27582380
DOI: 10.1093/jnci/djw172

No abstract available

Publication types

Letter
Comment

MeSH terms

BRCA2 Protein / genetics
Breast
Breast Neoplasms / genetics
Codon, Terminator*
Female
Genes, BRCA1
Genes, BRCA2
Genetic Predisposition to Disease
Humans
Male
Ovarian Neoplasms / genetics
Prostate*

Substances

BRCA2 Protein
BRCA2 protein, human
Codon, Terminator